Literature DB >> 31865508

Consider the microbiome in the equation! They were here before us...and hosted us!

José-Manuel Fernández-Real1, Massimo Federici2, Rémy Burcelin3.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31865508     DOI： 10.1007/s11154-019-09538-4

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  19 in total

Review 1.  The gut-brain axis: a major glucoregulatory player.

Authors:  R Burcelin
Journal:  Diabetes Metab       Date:  2010-10       Impact factor: 6.041

Review 2.  Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?

Authors:  Eduardo Esteve; Wifredo Ricart; Jose-Manuel Fernández-Real
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-09       Impact factor: 4.294

3.  The Gut Microbiota Regulates Intestinal CD4 T Cells Expressing RORγt and Controls Metabolic Disease.

Authors:  Lucile Garidou; Céline Pomié; Pascale Klopp; Aurélie Waget; Julie Charpentier; Meryem Aloulou; Anaïs Giry; Matteo Serino; Lotta Stenman; Sampo Lahtinen; Cedric Dray; Jason S Iacovoni; Michael Courtney; Xavier Collet; Jacques Amar; Florence Servant; Benjamin Lelouvier; Philippe Valet; Gérard Eberl; Nicolas Fazilleau; Victorine Douin-Echinard; Christophe Heymes; Rémy Burcelin
Journal:  Cell Metab       Date:  2015-07-07       Impact factor: 27.287

Review 4.  Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness.

Authors:  J M Fernández-Real; W Ricart
Journal:  Diabetologia       Date:  1999-11       Impact factor: 10.122

Review 5.  Dyslipidemia and inflammation: an evolutionary conserved mechanism.

Authors:  Eduardo Esteve; Wifredo Ricart; José Manuel Fernández-Real
Journal:  Clin Nutr       Date:  2005-02       Impact factor: 7.324

Review 6.  Insulin resistance and chronic cardiovascular inflammatory syndrome.

Authors:  José Manuel Fernández-Real; Wifredo Ricart
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

Review 7.  Gut microbiome and cardiometabolic risk.

Authors:  Ben Arpad Kappel; Massimo Federici
Journal:  Rev Endocr Metab Disord       Date:  2019-12       Impact factor: 6.514

8.  Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women.

Authors:  Lesley Hoyles; José-Manuel Fernández-Real; Massimo Federici; Matteo Serino; James Abbott; Julie Charpentier; Christophe Heymes; Jèssica Latorre Luque; Elodie Anthony; Richard H Barton; Julien Chilloux; Antonis Myridakis; Laura Martinez-Gili; José Maria Moreno-Navarrete; Fadila Benhamed; Vincent Azalbert; Vincent Blasco-Baque; Josep Puig; Gemma Xifra; Wifredo Ricart; Christopher Tomlinson; Mark Woodbridge; Marina Cardellini; Francesca Davato; Iris Cardolini; Ottavia Porzio; Paolo Gentileschi; Frédéric Lopez; Fabienne Foufelle; Sarah A Butcher; Elaine Holmes; Jeremy K Nicholson; Catherine Postic; Rémy Burcelin; Marc-Emmanuel Dumas
Journal:  Nat Med       Date:  2018-06-25       Impact factor: 53.440

Review 9.  Gut microbiota-derived succinate: Friend or foe in human metabolic diseases?

Authors:  Sonia Fernández-Veledo; Joan Vendrell
Journal:  Rev Endocr Metab Disord       Date:  2019-12       Impact factor: 6.514

Review 10.  The gut microbiota to the brain axis in the metabolic control.

Authors:  Estelle Grasset; Remy Burcelin
Journal:  Rev Endocr Metab Disord       Date:  2019-12       Impact factor: 6.514
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.